Live feed16:30:00·403dPRReleasevia QuantisnowPrecision BioSciences Accelerates Development of PBGENE-DMD Within its Wholly Owned Organic Pipeline and Highlights Pre-clinical Evidence at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingByQuantisnow·Wall Street's wire, on your screen.DTIL· Precision BioSciences Inc.Health Care
